Tens of thousands of people are still pursuing a glyphosate lawsuit against Bayer in 2026, and settlements ranging from $5,000 to over $200,000 are actively being paid out depending on the severity of the cancer diagnosis. If you or someone you love used Roundup weedkiller and later developed a serious illness, especially non-Hodgkin lymphoma, there is a real legal path available right now.
This is not a closed case. Litigation is ongoing at multiple court levels, and new claims are still being accepted.
In this article, you’ll learn exactly what the glyphosate lawsuit covers, which cancers and exposure types qualify, how payouts are structured, and what the 2026 deadlines look like. You’ll also get a clear breakdown of the difference between joining a class action and filing your own individual claim, because that choice alone can mean a difference of tens of thousands of dollars.
One fact that surprises most people: Bayer has already set aside over $16 billion to resolve Roundup-related claims. That fund is not infinite, and earlier filings generally fare better in the allocation process.
What Is the Glyphosate Lawsuit?
The glyphosate lawsuit is a mass legal action against Bayer AG (formerly Monsanto) claiming that Roundup weedkiller causes cancer, specifically non-Hodgkin lymphoma, and that the company failed to warn users about that risk.
Glyphosate is the active chemical ingredient in Roundup, the world’s most widely used herbicide. For decades, Monsanto marketed it as safe. In 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans,” placing it in Group 2A.
That classification triggered a wave of lawsuits. As of 2026, more than 160,000 claims have been filed across federal and state courts in the United States.
| Key Fact | Detail |
|---|---|
| Defendant | Bayer AG (acquired Monsanto in 2018) |
| Product | Roundup weedkiller (contains glyphosate) |
| Primary Allegation | Failure to warn about cancer risk |
| IARC Classification | Group 2A, “probably carcinogenic” |
| Total Claims Filed | 160,000+ as of 2026 |
| Settlement Reserve | Over $16 billion |
Bayer denies that glyphosate causes cancer. Despite that position, the company has paid billions to settle cases rather than face juries repeatedly. The legal battle is far from over.
Bayer Roundup Lawsuit Update 2026
In 2026, the Bayer Roundup lawsuit remains one of the largest product liability litigations in U.S. history, with active proceedings in federal multidistrict litigation (MDL) and state courts.
The key development heading into 2026 is the ongoing fallout from the U.S. Supreme Court’s handling of the federal preemption question. Bayer argued that because the EPA had approved glyphosate labels that did not include a cancer warning, state law failure-to-warn claims should be preempted. That argument has not fully prevailed, and state claims continue moving forward in courts across the country.
Bayer’s initial $10.9 billion settlement framework announced in 2020 collapsed when a federal judge rejected a proposed class settlement covering future claimants. That rejection sent Bayer back to resolve cases individually or through newer structured agreements.
| Year | Key Development |
|---|---|
| 2015 | IARC classifies glyphosate as probably carcinogenic |
| 2018 | First trial verdict: $289 million for Dewayne Johnson |
| 2019 | Second bellwether verdict: Edwin Hardeman wins $80 million |
| 2020 | Bayer announces $10.9B settlement framework |
| 2021 | Federal judge rejects future claimant class settlement |
| 2022-2023 | Appellate battles over preemption continue |
| 2024-2025 | Continued individual case resolutions and new filings |
| 2026 | Active MDL proceedings, new claim intake still open |
Bayer is clearly trying to contain financial exposure. But courts are not letting the company walk away cleanly. That pressure keeps the door open for new claimants in 2026.
Is the Glyphosate Lawsuit Still Active?
Yes, the glyphosate lawsuit is absolutely still active in 2026. New cases are being filed, existing cases are being resolved, and appellate courts are still deciding key legal questions that affect every pending claim.
Think of this litigation like a large river system. The main federal MDL channel (MDL 2741 in the Northern District of California) feeds into hundreds of tributaries in state courts. Settlements flow through some of those channels while new cases enter at other points. The whole system is still running.
Bayer has not achieved a blanket global settlement that closes the door on all future claims. The 2021 rejection of the proposed future claimants class is the most important reason why.
People who developed cancer after regular Roundup exposure can still file new claims in 2026, provided they meet the statute of limitations requirements specific to their state. Those windows vary, but they are not closed for most people.
Key point for 2026 filers: Bayer is more motivated than ever to resolve cases efficiently because trial losses continue to produce massive jury verdicts that attract media attention and shareholder pressure. That dynamic actually benefits new claimants who have strong cases.
What Is the Glyphosate Cancer Lawsuit About?
The glyphosate cancer lawsuit is specifically about whether Roundup causes cancer in humans and whether Monsanto (now Bayer) deliberately concealed that risk from consumers and regulators.
This is not just a personal injury claim. It’s a product liability case built on decades of internal Monsanto documents, scientific studies, and regulatory battles. Plaintiffs allege that Monsanto knew about glyphosate’s potential cancer risks as far back as the 1980s and chose not to disclose them.
Internal company emails and documents surfaced during discovery painted a picture of a company working to shape scientific research and influence regulatory decisions. Those documents became powerful evidence at trial and contributed to some of the largest early verdicts.
| Lawsuit Type | What It Claims |
|---|---|
| Failure to warn | Roundup labels did not disclose cancer risk |
| Defective design | Glyphosate itself is inherently dangerous |
| Fraud and concealment | Monsanto hid evidence of risk from regulators |
| Negligence | Company failed its duty of care to consumers |
At its core, the cancer lawsuit asks a simple question: if you knew your product might cause cancer, shouldn’t you have told people? Juries have repeatedly answered yes.
Key Takeaway: The glyphosate lawsuit is an active, ongoing mass tort rooted in failure-to-warn and product liability claims, with over 160,000 filed cases and more than $16 billion set aside by Bayer for resolution.
What Cancers Qualify for the Glyphosate Lawsuit?
Non-Hodgkin lymphoma is the primary cancer that qualifies for a glyphosate lawsuit, but several related blood cancers are also recognized in active claims.
The IARC’s 2015 report specifically linked glyphosate to non-Hodgkin lymphoma. That linkage became the scientific backbone of most lawsuits. All three bellwether trial victories involved plaintiffs with this diagnosis.
| Cancer Type | Qualification Status |
|---|---|
| Non-Hodgkin lymphoma (NHL) | Primary qualifying cancer, strongest scientific link |
| Diffuse large B-cell lymphoma | Subtype of NHL, widely accepted in claims |
| Follicular lymphoma | Subtype of NHL, accepted |
| Mantle cell lymphoma | Subtype of NHL, accepted |
| Chronic lymphocytic leukemia (CLL) | Reviewed on case-by-case basis |
| Multiple myeloma | Some claims accepted depending on exposure history |
| Hairy cell leukemia | Reviewed case-by-case |
| T-cell lymphomas | Certain subtypes reviewed |
Cancers that generally do not qualify include solid tumor cancers like lung, colon, or breast cancer unless there is a very specific documented exposure situation.
If your diagnosis falls into the NHL family of cancers, you are in the strongest qualifying position. Your medical records, the date of diagnosis, and your documented exposure to Roundup are the three most critical pieces of evidence.
Who Qualifies for the Glyphosate Lawsuit?
You may qualify for a glyphosate lawsuit if you used Roundup regularly and were later diagnosed with non-Hodgkin lymphoma or a related blood cancer.
The courts and settlement administrators look at several factors together, not just one in isolation. Qualifying is not automatic, but for people with a confirmed cancer diagnosis and a history of Roundup exposure, the threshold is often met.
Core eligibility requirements:
- Used Roundup or another glyphosate-based product for at least two years or on a regular basis
- Diagnosed with non-Hodgkin lymphoma or a qualifying related cancer after that exposure
- Cancer diagnosis occurred at least one year after initial significant exposure in most cases
- Claim is within the statute of limitations for your state
| Factor | What Strengthens Your Case |
|---|---|
| Exposure duration | Longer and more frequent use |
| Exposure type | Direct skin contact, no protective gear |
| Diagnosis timing | Cancer diagnosed after documented exposure period |
| Product identification | Can name Roundup specifically |
| Medical documentation | Biopsy, pathology report, oncologist records |
| Employment history | Worked in agriculture, landscaping, groundskeeping |
You do not need to have purchased Roundup yourself. Workers who were exposed on the job, family members of agricultural workers, and people who used neighbors’ or employers’ products can all potentially qualify.
What Is the Glyphosate Non-Hodgkin Lymphoma Lawsuit?
The glyphosate non-Hodgkin lymphoma lawsuit is the most legally supported category of claim within the broader Roundup litigation, backed by both IARC science and a series of trial victories.
Non-Hodgkin lymphoma (NHL) is a cancer that starts in the lymphatic system. It’s not one disease but a family of related cancers that affect white blood cells called lymphocytes. Glyphosate is alleged to damage DNA in ways that can lead to lymphocyte mutations that trigger NHL.
The three most important trial wins in this litigation all involved NHL:
- Dewayne Johnson (2018): School groundskeeper, awarded $289 million (later reduced to $78 million on appeal)
- Edwin Hardeman (2019): Homeowner who used Roundup for decades, awarded $80 million (later reduced to $25 million on appeal)
- Alva and Alberta Pilliod (2019): Couple who used Roundup for 35 years, awarded $2 billion (reduced to $87 million on appeal)
Even the reduced amounts are substantial. These cases validated the core science and the legal theory for everyone who followed.
If you have an NHL diagnosis and a documented history of Roundup use, your case sits in the most established category of this litigation.
Key Takeaway: Non-Hodgkin lymphoma is the strongest qualifying cancer for glyphosate lawsuits, supported by three trial wins and the IARC’s scientific classification of glyphosate as a probable human carcinogen.
Glyphosate Lawsuit for Farmers and Agricultural Workers
Farmers and agricultural workers represent the highest-exposure group in glyphosate litigation and often have the strongest individual cases due to documented, repeated, high-volume chemical contact.
If you’ve spent years applying Roundup or other glyphosate herbicides to crops, you’ve had far more exposure than a typical homeowner spraying a backyard. That matters enormously in these lawsuits. Courts look at cumulative exposure, and occupational applicators often show exposures ten to fifty times greater than residential users.
Groups that qualify in this category:
- Commercial farmers who applied glyphosate to crops
- Farm laborers who worked in fields treated with glyphosate
- Landscapers and groundskeepers (school districts, golf courses, parks)
- Nursery workers and greenhouse employees
- Pesticide applicators licensed or unlicensed
- Railroad and utility right-of-way maintenance crews
| Worker Type | Typical Exposure Level | Claim Strength |
|---|---|---|
| Commercial farmer | Very high, seasonal and annual | Very strong |
| Farm laborer | High, field re-entry exposure | Strong |
| Licensed pesticide applicator | Very high, direct mixing and spraying | Very strong |
| Groundskeeper | Moderate to high, frequent spraying | Strong |
| Homeowner | Low to moderate, occasional use | Moderate |
| Residential neighbor | Low, secondary exposure | Weaker, case-by-case |
Dewayne Johnson, the first plaintiff to win at trial, was a school groundskeeper. His case became the foundation for the entire litigation. Agricultural and occupational exposure cases continue to be prioritized in claim processing.
What Is the Glyphosate Lawsuit Settlement Amount?
Glyphosate lawsuit settlement amounts range from approximately $5,000 to over $200,000 for most resolved claims, with exceptional cases involving severe cancers and strong evidence reaching into the millions.
Settlement amounts are not publicly disclosed in most individual resolutions, but patterns have emerged from court filings, legal reporting, and MDL documentation. The amounts depend heavily on the severity of the cancer, the strength of the exposure evidence, and whether the plaintiff is living or deceased.
| Settlement Tier | Estimated Range | Typical Case Profile |
|---|---|---|
| Tier 1 (Highest) | $150,000 to $250,000+ | Aggressive NHL, extensive exposure, strong documentation |
| Tier 2 | $75,000 to $150,000 | Confirmed NHL, moderate exposure history |
| Tier 3 | $30,000 to $75,000 | Less aggressive cancer, some documentation gaps |
| Tier 4 (Lowest) | $5,000 to $30,000 | Limited exposure evidence, early-stage cancer |
| Wrongful Death | Varies widely | Estate claims, surviving spouse or children filing |
These figures come from patterns reported across resolved MDL claims and state court settlements. Individual outcomes vary.
Settlement amounts are also affected by your attorney’s negotiating position, the specific glyphosate product used, whether you can produce medical records dating the cancer to your exposure period, and whether your case would survive a Daubert challenge on expert witnesses.
Key Takeaway: Glyphosate lawsuit settlements are actively being paid in tiers ranging from roughly $5,000 to over $200,000, with case strength driven by cancer severity, exposure documentation, and medical record quality.
Glyphosate Lawsuit Payout Per Person
The average glyphosate lawsuit payout per person is estimated between $40,000 and $90,000, though that average masks a wide range from small resolved claims to multi-million-dollar individual verdicts.
Here’s how to think about it practically. The $16 billion Bayer reserve divided across the 160,000-plus filed claims would average roughly $100,000 per claim before legal fees, but that math is misleading. Not all claims will succeed. Many are weaker. Some were filed speculatively. The reserve also covers future claims and litigation costs.
Factors that push your payout higher:
- Diagnosis of an aggressive NHL subtype like diffuse large B-cell lymphoma
- Decades of occupational exposure with employment records to prove it
- Young age at diagnosis, because lifetime damages are calculated longer
- Punitive damages in cases showing deliberate concealment
- Cases that go to trial or are positioned for trial, which creates settlement pressure
Factors that lower the payout:
- Limited or poorly documented exposure history
- Early-stage or indolent cancer with low severity scores
- Statute of limitations issues that weaken the case
- Inability to identify Roundup specifically versus other glyphosate products
- Competing health factors that complicate causation arguments
Your attorney’s contingency fee typically runs 33% to 40% of the gross settlement, which is deducted before you receive payment. Factor that into your expectations when evaluating a settlement offer.
Roundup Lawsuit Settlement Update 2026
As of 2026, Bayer continues resolving Roundup lawsuit claims through a combination of individual settlements, structured agreements, and ongoing trial-ready case preparation that pressures future settlements.
Bayer has not announced a new global settlement fund since the 2020-era framework. Instead, the company is working through case groups negotiated by plaintiffs’ leadership counsel in the MDL. Cases with the strongest evidence profiles are being settled first.
2026 settlement landscape key points:
- Thousands of claims have been resolved as of early 2026
- New claims filed in 2025 and 2026 are entering a processing queue
- Bayer’s appellate strategy continues in federal circuits
- State court cases in California, Missouri, and Pennsylvania remain active
- The U.S. Supreme Court declined to definitively settle the preemption question, which leaves state failure-to-warn claims viable
| Metric | Current Status (2026) |
|---|---|
| Total claims filed | 160,000+ |
| Estimated claims resolved | 100,000+ |
| Claims still pending | 50,000 to 60,000+ |
| Bayer settlement reserve | $16B+ set aside |
| New claim intake | Still open |
| Next major legal milestone | Ongoing appellate decisions |
The settlement pipeline is moving but not closed. People entering the process in 2026 face a longer wait than early filers did, but their claims remain viable and Bayer remains under significant legal and financial pressure.
What Is the Glyphosate Class Action Lawsuit?
The glyphosate class action lawsuit refers to consolidated legal actions where multiple plaintiffs with similar claims against Bayer are grouped together, though the most significant Roundup claims are actually structured as a mass tort rather than a traditional class action.
This distinction matters more than most people realize. In a true class action, a group of plaintiffs shares one settlement divided among them. In a mass tort, each plaintiff maintains an individual claim and receives a separate, individually evaluated settlement. The Roundup litigation is primarily structured as a mass tort under the federal MDL system.
There have been attempts to certify certain Roundup claims as class actions, particularly for economic loss claims from people who bought Roundup and want refunds rather than injury compensation. Those consumer class actions are separate from the personal injury and cancer claims.
| Lawsuit Type | Structure | Payout Model |
|---|---|---|
| Mass tort (MDL) | Individual claims grouped for efficiency | Individual evaluation per plaintiff |
| Class action (consumer) | All class members share one settlement | Fixed per-person amount, often small |
| Individual state court | Standalone personal injury lawsuit | Fully individual negotiation or verdict |
For cancer claimants, the mass tort individual claim track almost always produces larger payouts than a consumer class action. Cancer is individual. Damages are individual. That’s why the MDL structure was designed for cases like this.
Key Takeaway: Most cancer claimants should pursue an individual mass tort claim through the Roundup MDL rather than a consumer class action, because individual evaluation produces significantly higher payouts for serious injury cases.
Glyphosate Class Action vs Individual Claim
Choosing between a glyphosate class action and an individual claim is one of the most important decisions a potential plaintiff can make, and in most cancer cases, the individual claim is the correct path.
Here’s the clearest way to explain it. A class action is like dividing a pizza equally among a hundred people. Everyone gets a slice, but it’s small. An individual claim is ordering your own pizza based on what you actually need. When your damages are serious, severe, and personal, individual evaluation almost always wins.
| Factor | Class Action | Individual Mass Tort Claim |
|---|---|---|
| Payout structure | Shared pool, fixed per-person amount | Individually negotiated or tried |
| Typical payout (cancer case) | $50 to a few hundred dollars | $5,000 to $200,000+ |
| Claim evaluation | No individual review of injuries | Full review of your medical history |
| Suitable for | Minor economic loss (refund type) | Cancer diagnosis, serious illness |
| Timeline | Often faster but lower value | Longer process, higher value |
| Control over outcome | Very little | More, with attorney guidance |
The consumer class actions in the Roundup litigation address things like pesticide purchases and property damage to organic crops. If you have cancer, you are not in that category. You need an individual personal injury claim filed in the MDL or in your state court.
Some law firms try to group clients into class structures for efficiency. Ask directly whether your claim will be individually evaluated. It should be.
How to File a Glyphosate Lawsuit
Filing a glyphosate lawsuit in 2026 starts with gathering your exposure history and medical records, then connecting with a mass tort attorney who handles Roundup claims specifically.
You cannot file directly into the MDL yourself without legal representation. The process requires an attorney who will evaluate your claim, gather evidence, draft the complaint, and file it in the appropriate court. Most Roundup attorneys work on contingency, meaning you pay nothing upfront and the attorney takes a percentage of your recovery.
Step-by-step filing process:
- Identify your exposure history: years of use, frequency, product name (Roundup specifically)
- Gather medical records confirming your cancer diagnosis and treatment dates
- Obtain employment records if your exposure was occupational
- Contact a mass tort attorney for a free case evaluation
- Attorney reviews your records and assesses claim strength
- Attorney files a complaint in federal MDL or state court
- Your case enters the litigation queue for settlement or trial
| Document | Why It Matters |
|---|---|
| Cancer diagnosis records | Proves the qualifying condition |
| Pathology/biopsy reports | Confirms cancer type and subtype |
| Oncologist treatment notes | Documents severity and prognosis |
| Purchase receipts (if available) | Links you to Roundup specifically |
| Employment history records | Proves occupational exposure |
| Photos of product use (if any) | Supporting evidence of direct contact |
| Timeline of exposure vs diagnosis | Establishes causation timeline |
Filing sooner rather than later matters. Statute of limitations clocks are running. Evidence gets harder to gather as time passes. And Bayer’s litigation fatigue works in your favor when you have a well-documented case positioned for trial.
What Is the Glyphosate Lawsuit Deadline in 2026?
The glyphosate lawsuit deadline in 2026 varies by state, but most statutes of limitations range from one to three years from the date you knew or reasonably should have known that your cancer was linked to Roundup.
This “discovery rule” is crucial. The clock does not necessarily start when you were first exposed to Roundup. It typically starts when you were diagnosed with cancer or when you first had reason to connect your cancer to your herbicide exposure.
| State | Statute of Limitations | Notes |
|---|---|---|
| California | 2 years from discovery | Discovery rule applies |
| Texas | 2 years from discovery | Strict enforcement |
| Florida | 2 years from discovery | Recent legislative changes, verify current law |
| New York | 3 years from discovery | Relatively generous window |
| Illinois | 2 years from discovery | Standard personal injury rule |
| Pennsylvania | 2 years from discovery | Discovery rule applies |
| Missouri | 5 years (general personal injury) | Longer window, Monsanto home state |
These are general guidelines. State laws change and individual circumstances affect how the clock runs. The safest approach is to consult with a mass tort attorney as soon as possible rather than trying to calculate the deadline yourself.
2026 warning: People diagnosed with NHL between 2022 and 2024 who have not yet filed may be approaching their deadline windows. Do not assume you have more time than you do.
What Is the Glyphosate Lawsuit Statute of Limitations?
The statute of limitations for a glyphosate lawsuit is the legal deadline by which you must file your claim or permanently lose the right to sue, and in 2026, many potential claimants are near or approaching that cutoff.
Most states apply the discovery rule to personal injury claims involving latent conditions like cancer. Under this rule, the clock starts when you discovered, or reasonably should have discovered, both the injury (the cancer) and its possible cause (Roundup exposure).
Factors that affect your specific deadline:
- Date of your cancer diagnosis
- Date you first read or heard about Roundup cancer risks
- Whether you consulted a doctor who mentioned pesticide exposure
- Whether you are filing as a surviving family member of a deceased Roundup user
- Whether your state has a separate rule for occupational disease claims
Wrongful death claims also have their own statute of limitations, which typically begins from the date of death rather than the date of diagnosis. Surviving spouses and children of Roundup users who have passed away from NHL should be aware that they may have separate but still expiring claim windows.
The bottom line: If you think you might have a claim, the statute of limitations is the single most important reason not to wait. Once it expires, no amount of strong evidence or compelling medical records can reopen your case.
How Long Does a Glyphosate Lawsuit Take to Settle?
A glyphosate lawsuit typically takes one to four years from the date of filing to reach a settlement, depending on when you file, the strength of your case, and where your claim falls in the MDL queue.
Early filers in 2019 and 2020 with strong NHL diagnoses saw resolution in roughly two to three years. Filers entering the system in 2025 and 2026 are looking at longer timelines because the MDL queue is substantial and trial scheduling is competitive.
| Filing Period | Estimated Resolution Timeline |
|---|---|
| Filed before 2021 | Most already resolved or near resolution |
| Filed 2021 to 2023 | 1 to 3 years from filing, many still in process |
| Filed 2024 to 2026 | Estimated 2 to 5 years from filing |
Cases that go to trial take longer but often produce larger verdicts. Cases that settle early in the process are resolved faster but sometimes for less. Your attorney’s strategic positioning matters a lot here.
Factors that speed up your case:
- Strong, well-documented medical records from the start
- Clear occupational exposure history
- Aggressive attorney with MDL experience
- Willingness to go to trial if necessary
Factors that slow it down:
- Incomplete documentation requiring additional discovery
- Daubert challenges to expert witness testimony
- Appellate delays in the broader MDL
- Bayer’s legal strategy to extend proceedings to reduce settlement pressure
Patience is part of this process. But entering the system now, with a solid case, positions you ahead of any future legislative changes or judicial decisions that could further complicate late-stage filings.
Key Takeaway: New glyphosate lawsuit filers in 2026 should expect a two-to-five-year resolution timeline, with faster outcomes for claimants who have complete documentation and experienced mass tort representation from the start.
Frequently Asked Questions
How much money can I get from a glyphosate lawsuit in 2026?
Most claimants receive between $5,000 and $200,000, with the average for well-documented NHL cases falling in the $40,000 to $90,000 range before attorney fees.
The exact amount depends on cancer severity, how well your exposure is documented, and whether your case carries any punitive damage potential.
Attorney fees typically run 33% to 40% of the gross settlement amount.
What cancers qualify for the glyphosate lawsuit?
Non-Hodgkin lymphoma is the primary qualifying cancer, covering subtypes like diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.
Some claims involving chronic lymphocytic leukemia, multiple myeloma, and hairy cell leukemia have also been accepted on a case-by-case basis.
Solid tumor cancers like lung, breast, or colon cancer generally do not qualify.
Is it too late to file a glyphosate lawsuit in 2026?
It is not too late for most people in 2026, but statute of limitations deadlines are running and some claimants may be close to their cutoff.
The deadline is typically two to three years from the date you were diagnosed with cancer or first had reason to connect your cancer to Roundup exposure.
People diagnosed with qualifying cancers between 2022 and 2024 should act quickly to verify their specific deadline.
What is the difference between the glyphosate class action and an individual lawsuit?
A class action divides one shared settlement among all plaintiffs, typically producing very small individual payouts, while an individual mass tort claim is separately evaluated and produces a payout based on your specific injuries.
Cancer claimants almost always receive significantly more compensation through the individual claim process in the Roundup MDL.
The consumer class actions in Roundup litigation primarily address product refunds and economic losses, not cancer compensation.
How long does a glyphosate lawsuit take to settle?
Cases filed in 2026 can expect a resolution timeline of roughly two to five years, depending on claim strength and MDL queue position.
Early filers with strong documentation tend to resolve faster because their cases are prioritized in settlement negotiations.
Going to trial can add time but often produces higher verdicts if the evidence is strong.
What You Should Know Before You File
The glyphosate lawsuit is one of the most significant product liability cases of the past decade. Bayer has paid out billions, thousands of people have already received settlements, and the litigation is still actively processing new claims in 2026.
If you used Roundup and developed non-Hodgkin lymphoma or a related blood cancer, your window to file is not closed, but it is narrowing. Statute of limitations deadlines are state-specific and unforgiving.
Start gathering your medical records, your exposure history, and any documentation of Roundup use. That groundwork is what separates a strong claim from a weak one. The sooner you have it organized, the better positioned you are when you connect with an attorney.
